Merck nears deal for rare-disease-drug maker Acceleron

Merck nears deal for rare-disease-drug maker Acceleron
Merck nears deal for rare disease drug maker Acceleron


Merck is in advanced talks to acquire Acceleron Pharma Inc., according to people familiar with the matter, in a move that would bolster the pharmaceutical giant’s rare-disease business. The deal for Acceleron, which has a market value of around $11 billion, could be announced this week, assuming talks don’t fall apart, the people said.



Source link

Be the first to comment

Leave a Reply

Your email address will not be published.


*